Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuhiro Kitajima

Showing results (191-200 of 242) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Disease|April 16, 2026
Real-world effectiveness and safety of adjuvant atezolizumab in pathological stage IIA-IIIB non-small cell lung cancer following curative surgeryAkifumi Nakamura, Nobuyuki Kondo, Seiji Matsumoto, et al.
Annals of Nuclear Medicine|June 15, 2011
Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?Kazuhiro Kitajima, Kayo Suzuki, Michio Senda, et al.
Annals of Nuclear Medicine|September 17, 2009
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter studyKazuhiro Kitajima, Koji Murakami, Kakuko Kanegae, et al.
Nagoya Journal of Medical Science|September 8, 2017
Diagnostic performance of <sup>11</sup>C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancerKazuhiro Kitajima, Kazuhito Fukushima, Shingo Yamamoto, et al.
Oncotarget|September 20, 2019
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOPKazuhiro Kitajima, Masaya Okada, Kyoko Yoshihara, et al.
Hellenic Journal of Nuclear Medicine|December 13, 2021
The utility of <sup>68</sup>F-FDG PET/CT for evaluation of tumor response to immune checkpoint inhibitor therapy and prognosis prediction in patients with non-small-cell lung cancerKazuhiro Kitajima, Yusuke Kawanaka, Hisashi Komoto, et al.
Breast (Edinburgh, Scotland)|August 30, 2016
Prognostic significance of preoperative <sup>18</sup>F-FDG PET/CT for breast cancer subtypesTomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, et al.
Journal of Cancer|August 21, 2018
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracilYukihisa Tamaki, Yoko Hieda, Masanobu Nakajima, et al.
Nagoya Journal of Medical Science|December 15, 2015
Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancerYukihisa Tamaki, Yoko Hieda, Rika Yoshida, et al.
BMC Cancer|November 15, 2022
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinomaHayato Kaida, Takushi Yasuda, Osamu Shiraishi, et al.
Pageof 25

Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Disease|April 16, 2026
Real-world effectiveness and safety of adjuvant atezolizumab in pathological stage IIA-IIIB non-small cell lung cancer following curative surgeryAkifumi Nakamura, Nobuyuki Kondo, Seiji Matsumoto, et al.
Annals of Nuclear Medicine|June 15, 2011
Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?Kazuhiro Kitajima, Kayo Suzuki, Michio Senda, et al.
Annals of Nuclear Medicine|September 17, 2009
Clinical impact of whole body FDG-PET for recurrent biliary cancer: a multicenter studyKazuhiro Kitajima, Koji Murakami, Kakuko Kanegae, et al.
Nagoya Journal of Medical Science|September 8, 2017
Diagnostic performance of <sup>11</sup>C-choline PET/CT and bone scintigraphy in the detection of bone metastases in patients with prostate cancerKazuhiro Kitajima, Kazuhito Fukushima, Shingo Yamamoto, et al.
Oncotarget|September 20, 2019
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOPKazuhiro Kitajima, Masaya Okada, Kyoko Yoshihara, et al.
Hellenic Journal of Nuclear Medicine|December 13, 2021
The utility of <sup>68</sup>F-FDG PET/CT for evaluation of tumor response to immune checkpoint inhibitor therapy and prognosis prediction in patients with non-small-cell lung cancerKazuhiro Kitajima, Yusuke Kawanaka, Hisashi Komoto, et al.
Breast (Edinburgh, Scotland)|August 30, 2016
Prognostic significance of preoperative <sup>18</sup>F-FDG PET/CT for breast cancer subtypesTomoko Higuchi, Arisa Nishimukai, Hiromi Ozawa, et al.
Journal of Cancer|August 21, 2018
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracilYukihisa Tamaki, Yoko Hieda, Masanobu Nakajima, et al.
Nagoya Journal of Medical Science|December 15, 2015
Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancerYukihisa Tamaki, Yoko Hieda, Rika Yoshida, et al.
BMC Cancer|November 15, 2022
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinomaHayato Kaida, Takushi Yasuda, Osamu Shiraishi, et al.
Pageof 25